Fundraising Fox

Trice Medical

Malvern, US · Founded 2011 · Delaware corporation

tricemedical.com

Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.

BiotechHealthtechMedical Devices

Founders & leadership

MF
Mark FosterExecutive
JO
Jeffrey O'DonnellNamed on SEC filing
SA
Steve AlmanyNamed on SEC filing
RK
Richard KienzleNamed on SEC filing
PK
Puneet KhannaNamed on SEC filing

Board

AD
Alan DavisBoard director
RS
Randy ScottBoard director
GK
Gary KurtzmanBoard director
MS
Michael SchraubenBoard director
VP
Vasant PadmanabhanBoard director

Reported raises · per SEC filings

Form D private placements

$123.2M disclosed across 9 rounds · 2012–2023

$10.5MraisedAug 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • NIMESH SHAHDirector
  • CHAD NORMANDirector
  • MICHAEL STEENExecutive Officer, Director
Offering amount
$17.5M
Amount sold
$10.5M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$7.3MraisedOct 2022 · 209 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • ALAN DAVISDirector
  • ERIC C. SALZMANDirector
  • MICHAEL SCHRAUBENDirector
  • MARK FOSTERExecutive Officer, Director
  • VASANT PADMANABHANDirector
  • CHRIS YAMAMOTODirector
  • RANDY SCOTTDirector
Offering amount
$7.3M
Amount sold
$7.3M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$27.6MraisedSep 2021 · 39 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael SchraubenDirector
  • Randy ScottDirector
  • Mark FosterExecutive Officer, Director
  • Alan DavisDirector
  • Gary KurtzmanDirector
  • Vasant PadmanabhanDirector
  • Chris YamamotoDirector
Offering amount
$37.6M
Amount sold
$27.6M
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$10.2MraisedApr 2021 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan DavisDirector
  • Randy ScottDirector
  • Mark FosterExecutive Officer, Director
  • Vasant PadmanabhanDirector
  • Gary KurtzmanDirector
  • Michael SchraubenDirector
Offering amount
$11M
Amount sold
$10.2M
Minimum investment
$1
Proceeds to insiders
$500K
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.1MraisedMar 2020 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan DavisDirector
  • Randy ScottDirector
  • Vasant PadmanabhanDirector
  • Michael SchraubenDirector
  • Craig K. CarraExecutive Officer
  • Gary KurtzmanDirector
  • Mark FosterExecutive Officer, Director
Offering amount
$6M
Amount sold
$2.1M
Minimum investment
$1
Proceeds to insiders
$700K
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$40.6MraisedJan 2019 · 47 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William A. HawkinsDirector
  • Randy ScottDirector
  • Mark FosterExecutive Officer
  • Vasant PadmanabhanDirector
  • Gary KurtzmanDirector
  • Mark SchraubonDirector
  • Alan DavisDirector
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
  • Craig CarraExecutive Officer
Offering amount
$42.3M
Amount sold
$40.6M
Minimum investment
$1
Finders' fees
$250K
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5MraisedDec 2016 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard WashburnExecutive Officer
  • Gary KurtzmanDirector
  • Craig CarraExecutive Officer
  • William A. HawkinsDirector
  • Steve AlmanyDirector
  • Garheng KongDirector
  • Jeffrey F. O'DonnellExecutive Officer, Director
  • Mark FosterExecutive Officer
Offering amount
$6.3M
Amount sold
$5M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$18.1MraisedJan 2015 · 30 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard KienzleDirector
  • Richard WashburnExecutive Officer
  • Garheng KongDirector
  • Jeffrey O'DonnellExecutive Officer, Director
  • Craig CarraExecutive Officer
  • Steve AlmanyDirector
  • Gary KurtzmanDirector
Offering amount
$18.1M
Amount sold
$18.1M
First sale
Jul 2014
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Trice Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Trice Medical do?
Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.
How much funding has Trice Medical raised?
Trice Medical has disclosed $123.2M raised across 9 rounds.
Where is Trice Medical headquartered?
Trice Medical is headquartered in Malvern, US.